NewLimit
Extending human healthspan with therapeutics that address aging at its cellular source
Healthcare & Biotech
AI, Robotics & Automation
Vision
NewLimit aims to extend the human healthspan with therapeutics that address aging at its cellular source. We are merging AI and genomics to produce reprogramming medicines that make old human cells function like young ones, giving everyone longer, healthier lives.
Sub-Industries
Cellular Reprogramming
Genomic Medicine
Longevity Therapeutics
Testimonial
Related Companies
Haply
Human interface layer for Physical AI, enabling robots to learn directly from human demonstration
Montreal, Canada
SymbyAI
AI co-pilot that automatically audits, replicates, and reviews scientific papers in minutes
Austin, TX, USA
KindBio
The future of organ replacement
Salem, NH, USA
The Embryo Corporation
Scalable embryo gene editing to build the next generation of animal life
Austin, TX, USA
Syncere
Ambient robotics for the home
Palo Alto, California, USA
Paterna Biosciecnes
In vitro gematogenesis platform company to address male and female intertility
Salt Lake City, UT, USA
Terminus Inudstrials
Reshoring and Automating Defense Grade Large Power Transformer Manufacturing
Austin, Texas, USA
